Top

Published in:

01-01-2023 | Dapagliflozin | Clinical study

Hospitalisation for acute kidney injury in patients initiating dapagliflozin

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The risk of hospitalisation for acute kidney injury (AKI) appears to be lower after initiation of dapagliflozin than after initiation of other antihyperglycaemics in patients with type 2 diabetes mellitus (T2DM), according to findings of an AstraZeneca-funded study published in Drug Safety. …

Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting Drug Safety : 17 Dec 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01263-3

Title: Hospitalisation for acute kidney injury in patients initiating dapagliflozin
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Dapagliflozin
Acute Kidney Injury
Acute Kidney Injury
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31418-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Hospitalisation for acute kidney injury in patients initiating dapagliflozin

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Aripiprazole/quetiapine

Levodopa/carbidopa/ropinirole

Linezolid

Enoximone/norepinephrine/warfarin

Pembrolizumab

Olanzapine/quetiapine/valproic acid